Patent Misuse: 6 Costly Traps and How to Avoid Them

Your patent can be valid, infringed, and still worthless in court — if you overreached when you licensed it. Patent misuse is an equitable defense that renders an otherwise enforceable patent unenforceable when the owner uses it to reach beyond what the grant actually covers. It does not invalidate the patent; it freezes your ability to sue until the misconduct is cured. Founders and in-house counsel rarely think about it until an accused infringer raises it, by which point the damage is done. This guide explains what patent misuse is, the landmark cases that define it, the six traps that trigger it, and how to purge it before it sinks an enforcement action.

What Patent Misuse Really Means

Patent misuse is a judge-made equitable doctrine. A court will refuse to enforce a patent — even against a clear infringer — if the owner has used the patent to broaden its scope, in time or in subject matter, with an anticompetitive effect. The classic formulation comes from Morton Salt Co. v. G.S. Suppiger Co., 314 U.S. 488 (1942), where the Supreme Court denied relief to a patentee that required licensees of its patented salt-depositing machine to also buy its unpatented salt tablets.

Two features make the doctrine dangerous. First, it is a defense, not a counterclaim: the accused infringer does not need to prove damages, only that you overreached. Second, the misuse does not have to be aimed at that defendant. Anyone you sue can point to a bad clause in an unrelated license and shut down your case until you fix it.

• It makes the patent unenforceable, not invalid — the claims survive.
• The remedy is denial of relief, not money damages against the patentee.
• It lasts only until the misuse is purged and its effects dissipate.
• Any accused infringer can raise it, regardless of who was harmed.

The Scope Test: Windsurfing and Princo

Modern courts do not treat every aggressive license term as misuse. The Federal Circuit narrowed the doctrine considerably. In Windsurfing International v. AMF, 782 F.2d 995 (Fed. Cir. 1986), the court held that a practice is misuse only if it broadens the physical or temporal scope of the patent grant and has an anticompetitive effect. Absent a specific statutory or precedential rule, the conduct is judged under a rule-of-reason analysis borrowed from antitrust law.

The en banc decision in Princo Corp. v. ITC, 616 F.3d 1318 (Fed. Cir. 2010), tightened it further. The court stressed that misuse requires leveraging the patent itself to gain market power beyond the grant — not merely engaging in conduct a plaintiff dislikes. A defendant who cannot tie the alleged harm to the patentee using the patent as leverage will usually lose the defense.

The practical takeaway: a normal license, even a hard-bargained one, is not misuse. The risk lives in a narrow set of terms that expand what the patent controls.

The Kimble Trap: Royalties After Expiration

The single most common way sophisticated parties stumble into misuse is by collecting royalties that run past the patent’s expiration. In Brulotte v. Thys Co., 379 U.S. 29 (1964), the Supreme Court held that charging royalties for use of an invention after the patent expires is unlawful per se. The Court reaffirmed the rule in Kimble v. Marvel Entertainment, 576 U.S. 446 (2015) — the Spider-Man web-shooter case — refusing on stare decisis grounds to overturn Brulotte even while conceding its economics were debatable.

You can lawfully spread payments for pre-expiration use over a longer period, or tie royalties to a portfolio with a later-expiring patent, or charge for know-how that outlives the patent. But a naked promise to keep paying patent royalties after the last claim expires is a textbook trigger. Draft the term structure with the expiration date in front of you.

Tying and the Section 271(d) Safe Harbor

Tying — conditioning a license on the licensee also buying a separate, unpatented product — is the conduct that created the doctrine in Morton Salt. But Congress pushed back. Under 35 U.S.C. § 271(d), several practices are expressly protected from a misuse finding.

1. Deriving revenue from acts that, if done by another, would be contributory infringement.
2. Licensing or authorizing others to perform such acts.
3. Seeking to enforce the patent against infringement or contributory infringement.
4. Refusing to license or use any rights in the patent.
5. Conditioning a license on the purchase of a separate product — unless the patentee has market power in the relevant market for the patented product.

That last clause, added by the Patent Misuse Reform Act of 1988, is decisive. Tying is only misuse today if you hold market power. A niche patent owner with substitutes in the market generally cannot commit tying misuse. A dominant one still can.

Misuse vs. Antitrust: Related but Not the Same

People conflate patent misuse with antitrust violations, and the overlap is real, but the doctrines diverge in ways that matter. Misuse is broader and easier to prove: a defendant does not need to establish a relevant market, market power (except in tying), or a completed Sherman or Clayton Act violation. It simply denies you your remedy.

Antitrust is broader in consequence. An antitrust violation exposes you to treble damages and attorney’s fees in a counterclaim, not just an unenforceable patent. A single licensing program can trigger both. When a term looks aggressive, ask two questions: does it expand the patent’s scope (misuse), and does it harm competition in a definable market (antitrust)? A clause can be misuse without being an antitrust violation, but rarely the reverse.

Six Traps That Trigger Patent Misuse

1. Post-expiration royalties. Collecting patent royalties after the claims expire — the Brulotte and Kimble rule.
2. Tying with market power. Forcing licensees to buy unpatented goods when you dominate the market for the patented one.
3. Mandatory package licensing. Refusing to license one needed patent unless the licensee takes unwanted patents too.
4. Overbroad field-of-use or territorial restrictions that reach conduct the patent does not cover.
5. Royalties on unpatented or non-infringing sales without a convenience-based option the licensee freely chose.
6. Coercive no-contest or grant-back terms that suppress challenges or extend control beyond the grant.

None of these is automatically fatal in every form — some, like total-sales royalty bases, are lawful when the licensee accepts them for convenience. The danger is coercion and scope expansion. When a clause makes the licensee pay for something the patent does not actually control, treat it as a red flag.

How to Purge Misuse Before It Costs You a Case

Misuse is curable. Under the purge doctrine, the defense evaporates once the patentee abandons the offending practice and its anticompetitive effects have dissipated — see B. Braun Medical v. Abbott Laboratories, 124 F.3d 1419 (Fed. Cir. 1997). The problem is timing: purging mid-litigation is expensive and may not undo the market effects fast enough to save the current suit.

• Audit every live license before you assert the patent, not after a defendant raises the defense.
• Strike or renegotiate post-expiration royalty tails and coercive tie-ins.
• Document the date you stopped the practice — the purge clock starts then.
• Coordinate licensing and litigation strategy so one program does not disarm the other.

Clean licensing is cheaper than a purge. Build misuse review into your IP enforcement strategy and your licensing agreements from the start, and align royalty terms with realistic patent royalty rates that end when the claims do.

How PerspireIP Can Help

Before you assert a patent, it pays to know that your own license terms will not be turned against you. PerspireIP helps patent owners audit licensing programs for misuse exposure, structure royalty and field-of-use terms that hold up, and build enforcement plans that survive an equitable defense. Contact our team to review your portfolio before the next dispute.

Frequently Asked Questions